Integral Health Asset Management as of March 31, 2020
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 51 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medtronic (MDT) | 4.6 | $10M | 115k | 90.18 | |
| Centene Corporation (CNC) | 4.4 | $10M | 170k | 59.41 | |
| Merck & Co (MRK) | 4.4 | $10M | 130k | 76.94 | |
| Bristol Myers Squibb (BMY) | 4.3 | $9.8M | 175k | 55.74 | |
| Quest Diagnostics Incorporated (DGX) | 4.2 | $9.6M | 120k | 80.30 | |
| BioMarin Pharmaceutical (BMRN) | 4.1 | $9.3M | 110k | 84.50 | |
| AstraZeneca (AZN) | 3.7 | $8.5M | 190k | 44.66 | |
| Catalent (CTLT) | 3.4 | $7.8M | 150k | 51.95 | |
| Chemocentryx | 3.4 | $7.6M | 190k | 40.18 | |
| Encompass Health Corp (EHC) | 3.2 | $7.4M | 115k | 64.03 | |
| LHC | 3.1 | $7.0M | 50k | 140.20 | |
| Danaher Corporation (DHR) | 3.0 | $6.9M | 50k | 138.42 | |
| Gw Pharmaceuticals Plc ads | 2.9 | $6.6M | 75k | 87.57 | |
| Masimo Corporation (MASI) | 2.7 | $6.2M | 35k | 177.11 | |
| Novartis (NVS) | 2.5 | $5.8M | 70k | 82.46 | |
| Becton, Dickinson and (BDX) | 2.5 | $5.7M | 25k | 229.76 | |
| Agios Pharmaceuticals (AGIO) | 2.3 | $5.3M | 150k | 35.48 | |
| Sage Therapeutics (SAGE) | 2.2 | $4.9M | 170k | 28.72 | |
| EXACT Sciences Corporation (EXAS) | 2.0 | $4.6M | 80k | 58.00 | |
| Arena Pharmaceuticals | 2.0 | $4.6M | 110k | 42.00 | |
| Boston Scientific Corporation (BSX) | 1.8 | $4.1M | 125k | 32.63 | |
| Nevro (NVRO) | 1.8 | $4.0M | 40k | 99.97 | |
| Dentsply Sirona (XRAY) | 1.7 | $3.9M | 100k | 38.83 | |
| Cytokinetics (CYTK) | 1.7 | $3.8M | 320k | 11.79 | |
| Chewy Inc cl a (CHWY) | 1.7 | $3.7M | 100k | 37.49 | |
| Walgreen Boots Alliance (WBA) | 1.6 | $3.7M | 80k | 45.75 | |
| Abbott Laboratories (ABT) | 1.6 | $3.6M | 45k | 78.91 | |
| Blueprint Medicines (BPMC) | 1.5 | $3.5M | 60k | 58.48 | |
| Intuitive Surgical (ISRG) | 1.5 | $3.5M | 7.0k | 495.14 | |
| Dicerna Pharmaceuticals | 1.5 | $3.4M | 185k | 18.37 | |
| PerkinElmer (RVTY) | 1.5 | $3.4M | 45k | 75.29 | |
| McKesson Corporation (MCK) | 1.5 | $3.4M | 25k | 135.28 | |
| Novo Nordisk A/S (NVO) | 1.5 | $3.3M | 55k | 60.20 | |
| Mirati Therapeutics | 1.4 | $3.1M | 40k | 76.88 | |
| Exelixis (EXEL) | 1.1 | $2.6M | 150k | 17.22 | |
| UnitedHealth (UNH) | 1.1 | $2.5M | 10k | 249.40 | |
| 10x Genomics Inc Cl A (TXG) | 1.1 | $2.5M | 40k | 62.33 | |
| Alkermes (ALKS) | 1.0 | $2.2M | 150k | 14.42 | |
| Fate Therapeutics (FATE) | 0.9 | $2.1M | 95k | 22.21 | |
| Karyopharm Therapeutics (KPTI) | 0.8 | $1.9M | 100k | 19.21 | |
| Exelixis Inc Cmn Stk cmn | 0.8 | $1.7M | 100k | 17.22 | |
| Rts/bristol-myers Squibb Compa | 0.8 | $1.7M | 450k | 3.80 | |
| Arvinas Ord (ARVN) | 0.7 | $1.6M | 40k | 40.30 | |
| Denali Therapeutics (DNLI) | 0.7 | $1.6M | 90k | 17.51 | |
| Humana (HUM) | 0.7 | $1.6M | 5.0k | 314.00 | |
| Akebia Therapeutics (AKBA) | 0.7 | $1.5M | 200k | 7.58 | |
| Minerva Neurosciences | 0.7 | $1.5M | 250k | 6.02 | |
| Akero Therapeutics (AKRO) | 0.6 | $1.3M | 60k | 21.20 | |
| Halozyme Therapeutics (HALO) | 0.4 | $900k | 50k | 18.00 | |
| Amarin Corp Plc option | 0.4 | $800k | 200k | 4.00 | |
| Pfenex | 0.3 | $750k | 85k | 8.82 |
